Sign in

CIK 0001157601 · Large accelerated filer

MADRIGAL PHARMACEUTICALS, INC.

Sign in to watch
Ticker
MDGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(267) 824-2827
Business address
1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
Former names
MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
  1. SC 13G/A Stake Amended Statement of Ownership
  2. 4 Grant or award Director acquired 4,000 shares (grant or award)
  3. 4 Grant or award Director acquired 10,000 shares (grant or award)
  4. 4 Grant or award Director acquired 16,000 shares (grant or award)
  5. 4 Grant or award Director acquired 2,000 shares (grant or award)
  6. 4 Grant or award Director acquired 8,000 shares (grant or award)
  7. 4 Open-market buy Director bought 150,000 shares at $4.71 ($706,515)
  8. 4 Open-market buy President and CEO bought 10,000 shares at $5.03 ($50,299)
  9. SC 13D/A Stake Beneficial Ownership Report
  10. 4 Open-market buy Director bought 500,000 shares at an average $4.53 ($2,265,390)
  11. 4 Open-market buy Director bought 250,000 shares at an average $4.39 ($1,097,440)
  12. 4 Open-market buy President and CEO bought 20,000 shares at $4.12 ($82,374)
  13. 4 Open-market buy Director bought 200,000 shares at $4.00 ($799,160)
  14. 8-K Event Bylaws or fiscal year change · Shareholder vote results
  15. 4 Open-market buy President and CEO bought 10,000 shares at $4.06 ($40,550)
  16. SC 13D/A Stake Beneficial Ownership Report
  17. 4 Open-market buy President and CEO bought 10,000 shares at $4.04 ($40,390)
  18. 4 Open-market buy Director bought 2,000,000 shares at an average $4.64 ($9,270,354)
  19. 4 Open-market buy SVP, Chief Medical Officer bought 10,000 shares at $4.58 ($45,800)
  20. 4 Open-market buy Director bought 10,000 shares at $5.00 ($50,000)

Page 42 of 62 · 1,224 filings